Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Combining the mTOR Inhibitor Everolimus and Gemcitabine in Relapsed/Refractory Peripheral T-Cell Lymphomas

Ling Huang, MD, Xinmiao Jiang, MD, Wenyu Li, PhD, Hanguo Guo, Xiaojuan Wei, Sichu Liu, MD, Feili Chen, Zhanli Liang

Blood (2020) 136 (Supplement 1): 31–32.

https://doi.org/10.1182/blood-2020-142364

Published: 2020

Journal Articles

Ctdna Monitoring in Predicting Relapse of Primary Mediastinal B-Cell Lymphoma

Diwen Pang, Xinmiao Jiang, MD, Ling Huang, MD, Yan Teng, Sichu Liu, MD, Feili Chen, Xiaojuan Wei, Hanguo Guo, Wenyu Li, PhD

Blood (2020) 136 (Supplement 1): 36.

https://doi.org/10.1182/blood-2020-142349

Published: 2020

Journal Articles

Clinical Characteristic and Survival Outcome of Peripheral T Cell Lymphoma in a Chinese Population

Wenyu Li, MD PhD, Ling Huang, MD, Xinmiao Jiang, MD, Xiaojuan Wei, Hanguo Guo, Liu Sichu, MD, Chen Feili, MD, Zhanli Liang

Blood (2019) 134 (Supplement_1): 5271.

https://doi.org/10.1182/blood-2019-129552

Published: 2019

Journal Articles

TRAF1-ALK Fusion Predicts Poor Prognosis for ALK Positive Anaplastic Large Cell Lymphoma Patients with Chemotherapy and ALK Inhibitor

Ling Huang, MD, Xinmiao Jiang, MD, Hanguo Guo, Liu Sichu, MD, Xiaojuan Wei, Chen Feili, MD, Zhanli Liang, Wenyu Li, MD PhD

Blood (2019) 134 (Supplement_1): 5224.

https://doi.org/10.1182/blood-2019-126541

Published: 2019

Journal Articles

Comprehensive Genomic Profiling of Adult T-Cell Lymphoblastic Lymphoma in Chinese Patients

Feili Chen, Hanguo Guo, Ling Huang, MD, Xinmiao Jiang, MD, Xiaojuan Wei, Wenyu Li, MD PhD

Blood (2019) 134 (Supplement_1): 5039.

https://doi.org/10.1182/blood-2019-126624

Published: 2019

Journal Articles

Next Generation Sequencing Highlights the Role of Cell Cycle and Apoptosis Dysregulation and Hepatitis B Infection in Refractory Diffuse Large B Cell Lymphoma

Wenyu Li, PhD, Xinmiao Jiang, Hanguo Guo, Xiaojuan Wei, Feili Chen, Sichu Liu, MD, Ling Huang, MD, Zhanli Liang

Blood (2017) 130 (Supplement 1): 5131.

https://doi.org/10.1182/blood.V130.Suppl_1.5131.5131

Published: 2017

NARROW

Combining the mTOR Inhibitor Everolimus and Gemcitabine in Relapsed/Refractory Peripheral T-Cell Lymphomas

Ctdna Monitoring in Predicting Relapse of Primary Mediastinal B-Cell Lymphoma

Clinical Characteristic and Survival Outcome of Peripheral T Cell Lymphoma in a Chinese Population

TRAF1-ALK Fusion Predicts Poor Prognosis for ALK Positive Anaplastic Large Cell Lymphoma Patients with Chemotherapy and ALK Inhibitor

Comprehensive Genomic Profiling of Adult T-Cell Lymphoblastic Lymphoma in Chinese Patients

Next Generation Sequencing Highlights the Role of Cell Cycle and Apoptosis Dysregulation and Hepatitis B Infection in Refractory Diffuse Large B Cell Lymphoma

Email alerts

ASH Publications

American Society of Hematology

Combining the mTOR Inhibitor Everolimus and Gemcitabine in Relapsed/Refractory Peripheral T-Cell Lymphomas

Ctdna Monitoring in Predicting Relapse of Primary Mediastinal B-Cell Lymphoma

Clinical Characteristic and Survival Outcome of Peripheral T Cell Lymphoma in a Chinese Population

TRAF1-ALK Fusion Predicts Poor Prognosis for ALK Positive Anaplastic Large Cell Lymphoma Patients with Chemotherapy and ALK Inhibitor

Comprehensive Genomic Profiling of Adult T-Cell Lymphoblastic Lymphoma in Chinese Patients

Next Generation Sequencing Highlights the Role of Cell Cycle and Apoptosis Dysregulation and Hepatitis B Infection in Refractory Diffuse Large B Cell Lymphoma

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only